Literature DB >> 14642204

Plasmodium vivax malaria in spite of atovaquone/proguanil (malarone) prophylaxis.

Laura Povinelli1, Tim A Monson, Barry C Fox, Monica E Parise, Joanne M Morrisey, Akhil B Vaidya.   

Abstract

A 70-year-old male scientist, who had returned 5 weeks earlier from Ethiopia, was admitted to the hospital with symptoms consistent with malaria. On physical examination, he had orthostatic hypotension. He was dehydrated and showed a mild clinical delirium. Abdominal examination revealed a possible spleen tip, and he had petechial lesions bilaterally below his knees. Laboratory data revealed his white blood cell count to be 4,500/mL, with 67% polymorphonuclear cells and 15% band forms. The hemoglobin level was 13.9 g/dL, and the platelet count was low, at 32,000/mL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14642204     DOI: 10.2310/7060.2003.9318

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  8 in total

Review 1.  Review: Malaria chemoprophylaxis for travelers to Latin America.

Authors:  Laura C Steinhardt; Alan J Magill; Paul M Arguin
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery.

Authors:  Laurent Dembele; Audrey Gego; Anne-Marie Zeeman; Jean-François Franetich; Olivier Silvie; Armelle Rametti; Roger Le Grand; Nathalie Dereuddre-Bosquet; Robert Sauerwein; Geert-Jan van Gemert; Jean-Christophe Vaillant; Alan W Thomas; Georges Snounou; Clemens H M Kocken; Dominique Mazier
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

3.  Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles.

Authors:  Wesley Nyaigoti Omwoyo; Bernhards Ogutu; Florence Oloo; Hulda Swai; Lonji Kalombo; Paula Melariri; Geoffrey Maroa Mahanga; Jeremiah Waweru Gathirwa
Journal:  Int J Nanomedicine       Date:  2014-08-11

4.  Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb.

Authors:  Beatrix Huei-Yi Teo; Paul Lansdell; Valerie Smith; Marie Blaze; Debbie Nolder; Khalid B Beshir; Peter L Chiodini; Jun Cao; Anna Färnert; Colin J Sutherland
Journal:  PLoS Negl Trop Dis       Date:  2015-10-20

5.  Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection.

Authors:  Chaisith Sivakorn; Polrat Wilairatana; Srivicha Krudsood; Marcus J Schultz; Tachpon Techarang; Khanittha Kheawsawaung; Arjen M Dondorp
Journal:  Malar J       Date:  2021-01-07       Impact factor: 2.979

6.  Atovaquone-Proguanil in Combination With Artesunate to Treat Multidrug-Resistant P. falciparum Malaria in Cambodia: An Open-Label Randomized Trial.

Authors:  Mariusz Wojnarski; Chanthap Lon; Pattaraporn Vanachayangkul; Panita Gosi; Somethy Sok; Agus Rachmat; Dustin Harrison; Catherine M Berjohn; Michele Spring; Suwanna Chaoratanakawee; Mali Ittiverakul; Nillawan Buathong; Soklyda Chann; Saowaluk Wongarunkochakorn; Andreea Waltmann; Worachet Kuntawunginn; Mark M Fukuda; Hana Burkly; Vireak Heang; Thay Keang Heng; Nareth Kong; Threechada Boonchan; Bolin Chum; Philip Smith; Andrew Vaughn; Satharath Prom; Jessica Lin; Dysoley Lek; David Saunders
Journal:  Open Forum Infect Dis       Date:  2019-09-04       Impact factor: 3.835

7.  Suppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malaria.

Authors:  J Kevin Baird
Journal:  Travel Med Infect Dis       Date:  2013-02-28       Impact factor: 6.211

8.  Mixed-species Plasmodium falciparum and Plasmodium ovale malaria in a paediatric returned traveller.

Authors:  Heather Senn; Nadia Alattas; Andrea K Boggild; Shaun K Morris
Journal:  Malar J       Date:  2014-03-05       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.